What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
The scientist’s investigation covers issues in Pathology, Lymphoma, Antigen, Antibody and Immunology.
His Pathology research includes themes of B cell and Internal medicine, Lymphocyte.
His Lymphoma study combines topics from a wide range of disciplines, such as Carcinogenesis, Fluorescence in situ hybridization, Cancer research and Large cell.
His Antigen research integrates issues from Antigen-presenting cell and Monoclonal.
His research on Antibody often connects related areas such as Molecular biology.
His work in the fields of Immune system and Lymphoid neoplasms overlaps with other areas such as World health.
His most cited work include:
- A revised European-American classification of lymphoid neoplasms : a proposal from the international lymphoma study group (5849 citations)
- Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. (3553 citations)
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms (3041 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Pathology, Lymphoma, Cancer research, Internal medicine and Molecular biology.
His research integrates issues of T cell, Antibody, Monoclonal antibody and Antigen in his study of Pathology.
Harald Stein combines subjects such as CD30, Immune system and Monoclonal with his study of Antigen.
The various areas that Harald Stein examines in his Lymphoma study include Immunophenotyping and B cell.
His Cancer research research is multidisciplinary, relying on both Gene expression, Carcinogenesis, Apoptosis, Anaplastic large-cell lymphoma and Regulation of gene expression.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Surgery and Oncology.
He most often published in these fields:
- Pathology (44.30%)
- Lymphoma (32.90%)
- Cancer research (22.02%)
What were the highlights of his more recent work (between 2010-2020)?
- Internal medicine (20.73%)
- Lymphoma (32.90%)
- Oncology (8.55%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Lymphoma, Oncology, Pathology and Cancer research.
In his work, Gene mutation and Histopathology is strongly intertwined with Surgery, which is a subfield of Internal medicine.
Harald Stein has researched Lymphoma in several fields, including Survival rate and Gastroenterology.
His Pathology research includes elements of Young adult, Immunophenotyping and Chromosomal translocation.
Harald Stein has included themes like Mutation, Hematology, Regulation of gene expression and BCL6 in his Cancer research study.
His studies examine the connections between CD30 and genetics, as well as such issues in Anaplastic large-cell lymphoma, with regards to Molecular biology, Histone H3, Histone methyltransferase, Chromatin immunoprecipitation and Histone H2A.
Between 2010 and 2020, his most popular works were:
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms (3041 citations)
- The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. (1270 citations)
- Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial (406 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
Harald Stein mainly focuses on Lymphoma, Internal medicine, Surgery, Hodgkin's lymphoma and Pathology.
His research in Lymphoma intersects with topics in Survival rate, Cancer research and Survival analysis.
His Internal medicine study combines topics in areas such as Gastroenterology and Oncology.
His Hodgkin's lymphoma research incorporates elements of Procarbazine, Regimen and ABVD.
His research integrates issues of NODAL and Immunophenotyping in his study of Pathology.
His Diffuse large B-cell lymphoma study integrates concerns from other disciplines, such as RNA, Real-time polymerase chain reaction, Molecular biology, Virus and microRNA.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
